Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   HTML views PDF downloads Totals
18,867 Dovepress* 10,935+ 1,919 12,854
PubMed Central* 7,932 1,102 9,034
Totals 18,867 3,021 21,888
*Since 14 July 2017
Total mentioned Facebook Delicious Reddit Twitter Others
14 1 0 0 4 9

View citations on PubMed Central and Google Scholar